 |
|
|
| |
ABBV-382, an Anti-a4b7 Ab That Enhances
HIV-1 Antigen Presentation for Immune-Mediated Viral Control
|
| |
| |
CROI 2024 March 3-6 Denver
Teresa I. Ng1, Gautam K. Sahu2, Domenick E. Kennedy1, Tatyana Dekhtyar1, Renee Miller2, Liangjun Lu1, Dolonchampa Maji1, Silvino Sousa2, Keenan Taylor2, Sahana Bose2, Joel F. Cohen-Solal2, Axel Hernandez2, Victoria Pitney2, Melanie Patterson1, Jochen Salfeld2
1AbbVie Inc., 1 North Waukegan Rd., North Chicago, IL 60064, USA; 2AbbVie Bioresearch Center, 100 Research Drive, Worcester, MA 01605, USA
|
| |
|
|
|
|
|
